<DOC>
	<DOCNO>NCT00458848</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy work different way stop growth cancer cell , either kill cell stop dividing . Imatinib mesylate may stop growth cancer cell block enzymes need cell growth . A peripheral stem cell transplant may able replace blood-forming cell destroy chemotherapy . When healthy stem cell infused patient may help patient 's bone marrow make stem cell , red blood cell , white blood cell , platelet . Giving combination chemotherapy together imatinib mesylate peripheral stem cell transplant may effective treatment acute lymphoblastic leukemia . Nevertheless , last year GIMEMA pubblished paper 100 % Ph+ ALL patient reach HCR Imatinib , without chemiotherapy . Thus , treatment implement patient pertain category .</brief_summary>
	<brief_title>Chemotherapy With Without Imatinib and/or Peripheral Stem Cell Transplant Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<mesh_term>Idarubicin</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute lymphoblastic leukemia ( ALL ) meeting follow criterion : Negative myeloperoxidase stain Phenotype T ( TALL ) B ( BALL ) No mature BALL ( FAB L3 , serum immunoglobulinpositive , terminal deoxynucleotidyl transferasenegative ) PATIENT CHARACTERISTICS : Creatinine ≤ 2.5 mg/dL ( adequate hydration ) SGOT SGPT ≤ 3 time upper limit normal LVEF ≥ 50 % No severe psychiatric disorder No concurrent malignant disease No presence document infection respond antibiotic and/or antifungal therapy Not pregnant PRIOR CONCURRENT THERAPY : No prior steroid No prior antiblastic chemotherapy No concurrent chemotherapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>B-cell adult acute lymphoblastic leukemia</keyword>
	<keyword>T-cell adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>L1 adult acute lymphoblastic leukemia</keyword>
	<keyword>L2 adult acute lymphoblastic leukemia</keyword>
	<keyword>TdT positive adult acute lymphoblastic leukemia</keyword>
</DOC>